The clinical performance is complex and often involves multiple systemic stresses. Early identification and standardized clinical treatment are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical performance, imaging, laboratory testing and pathological evaluation.
The platform can help to align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. Treatment and management of PML-associated brain hemispheres require individualized development of treatment plans, typically including multidimensional management of drug therapy, rehabilitation, and regular follow-up visits. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved.
Treatment needs to be closely monitored for effectiveness and adverse reactions, adapted to the timely schedule of disease changes. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of congestive brain hemispheres associated with PML. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.